INSIG1 and neoplasm: Intravenous delivery of the Insig1/2 loop 1 peptide effectively attenuated tumor growth, prolonged mouse survival, inhibited the PCK1‐Insig‐SREBP‐lipid production axis, and increased cell apoptosis in tumor tissues.